Cancer Research and Treatment

OCT 8, 2026 · REVIEW

Strategy Integrating Stereotactic Body Radiation Therapy with Immune Checkpoint Inhibitors for Oligometastatic Non-Small Cell Lung Cancer: A Narrative Review

Cancer Research and Treatment

The therapeutic approach for oligometastatic non-small cell lung cancer (NSCLC) is rapidly shifting from palliative care to curative-intent strategies. This shift is largely driven

SEP 16, 2026 · JOURNAL ARTICLE

Ablative SABR for Pulmonary Oligometastases in the Era of Contemporary Systemic Therapies: Efficacy, Safety, and Optimal Sequencing

Cancer Research and Treatment

PurposeThis study evaluated the efficacy and safety of stereotactic ablative radiotherapy (SABR) for pulmonary metastases in the era of contemporary systemic therapy and identified

AUG 10, 2026 · JOURNAL ARTICLE

Early On-Treatment Host Fitness Dynamics Refine Prognostic Stratification in Advanced NSCLC Receiving First-Line Immunotherapy

Cancer Research and Treatment

Prospective multicenter trial of 441 patients shows early on-treatment PNI refines prognosis in advanced NSCLC on immunotherapy with statistically significant associations for PFS and OS, but uses a surrogate nutritional biomarker rather than direct clinical intervention.